Avid Bioservices Inc (CDMO)
10.49
+0.22
(+2.14%)
USD |
NASDAQ |
Nov 04, 13:08
Avid Bioservices Revenue (Quarterly): 40.17M for July 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 40.17M |
| April 30, 2024 | 42.98M |
| January 31, 2024 | 33.82M |
| October 31, 2023 | 25.40M |
| July 31, 2023 | 37.73M |
| April 30, 2023 | 39.80M |
| January 31, 2023 | 38.02M |
| October 31, 2022 | 34.76M |
| July 31, 2022 | 36.69M |
| April 30, 2022 | 31.23M |
| January 31, 2022 | 31.51M |
| October 31, 2021 | 26.11M |
| July 31, 2021 | 30.75M |
| April 30, 2021 | 27.61M |
| January 31, 2021 | 21.81M |
| October 31, 2020 | 21.06M |
| July 31, 2020 | 25.39M |
| April 30, 2020 | 12.55M |
| January 31, 2020 | 13.58M |
| October 31, 2019 | 18.31M |
| July 31, 2019 | 15.25M |
| April 30, 2019 | 17.06M |
| January 31, 2019 | 13.78M |
| October 31, 2018 | 10.18M |
| July 31, 2018 | 12.59M |
| Date | Value |
|---|---|
| April 30, 2018 | 6.943M |
| January 31, 2018 | 6.819M |
| October 31, 2017 | 12.78M |
| July 31, 2017 | 27.08M |
| April 30, 2017 | 17.90M |
| January 31, 2017 | 10.75M |
| October 31, 2016 | 23.37M |
| July 31, 2016 | 5.609M |
| April 30, 2016 | 18.45M |
| January 31, 2016 | 6.709M |
| October 31, 2015 | 9.523M |
| July 31, 2015 | 9.671M |
| April 30, 2015 | 9.308M |
| January 31, 2015 | 5.677M |
| October 31, 2014 | 6.30M |
| July 31, 2014 | 5.496M |
| April 30, 2014 | 6.474M |
| January 31, 2014 | 3.885M |
| October 31, 2013 | 7.354M |
| July 31, 2013 | 4.688M |
| April 30, 2013 | 4.254M |
| January 31, 2013 | 7.039M |
| October 31, 2012 | 6.139M |
| July 31, 2012 | 4.251M |
| April 30, 2012 | 2.065M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
12.55M
Minimum
Apr 2020
42.98M
Maximum
Apr 2024
30.05M
Average
31.23M
Median
Apr 2022
Revenue (Quarterly) Benchmarks
| MEI Pharma Inc | -- |
| Altimmune Inc | 0.005M |
| NovaBay Pharmaceuticals Inc | 2.40M |
| Palatin Technologies Inc | 0.35M |
| iBio Inc | 0.175M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.534M |
| Total Expenses (Quarterly) | 42.63M |
| EPS Diluted (Quarterly) | -0.09 |
| Enterprise Value | 775.66M |
| Gross Profit Margin (Quarterly) | 14.22% |
| Profit Margin (Quarterly) | -13.78% |
| Earnings Yield | -21.64% |
| Normalized Earnings Yield | -21.64 |